Invention Application
US20100168052A1 Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation
审中-公开
治疗EBV和KHSV感染和相关异常细胞增殖
- Patent Title: Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation
- Patent Title (中): 治疗EBV和KHSV感染和相关异常细胞增殖
-
Application No.: US12647959Application Date: 2009-12-28
-
Publication No.: US20100168052A1Publication Date: 2010-07-01
- Inventor: Raymond F. Schinazi , Junxing Shi , Erik Gustafson , Joyce D. Fingeroth
- Applicant: Raymond F. Schinazi , Junxing Shi , Erik Gustafson , Joyce D. Fingeroth
- Applicant Address: US NJ Princeton US GA Atlanta US MA Boston
- Assignee: Pharmasset, Inc.,EMORY UNIVERSITY,BETH ISRAEL DEACONESS MEDICAL CENTER
- Current Assignee: Pharmasset, Inc.,EMORY UNIVERSITY,BETH ISRAEL DEACONESS MEDICAL CENTER
- Current Assignee Address: US NJ Princeton US GA Atlanta US MA Boston
- Main IPC: A61K31/7034
- IPC: A61K31/7034 ; A61K31/513 ; A61P35/00 ; A61P31/00 ; C12N5/073
Abstract:
A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.
Information query
